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1. Introduction 
The antibiotic, rifamycin SV, has been characterized 
as a potent inhibitor of the initiation of RNA synthesis 
by certain prokaryotic RNA polymerases [ 1 ] . The 
characteristics of inhibition by rifamycin SV resemble 
those described for the chelating agent, 1: IO-phenan- 
throline [2], and binding studies indicate that both 
these inhibitors pecifically prevent he low affinity 
interaction of prokaryotic RNA polymerase with 
purine nucleotides which occurs in the absence of 
added divalent metal ions [3]. Since prokaryotic RNA 
polymerase has been shown to be a zinc metallo- 
enzyme [2], it seemed possible that inhibition by 
both rifamycin SV and 1: lo-phenanthroline might 
result from interaction with the bound metal ion. 
During EPR studies designed to measure the affinity 
of rifamycin SV for Mn” it was noted that the colour 
of the test solutions changed from yellow to deep red 
during the period of observation. Since this colour 
change appeared ependent on addition of Mn”, 
further studies were performed to elucidate the 
nature of the effect. These studies have shown that 
certain divalent metal ions are effective catalysts of 
the oxidation of rifamycin SV to rifamycin S. The 
effect may explain the previous report that rifamycin 
SV is unstable in solution and undergoes spontaneous 
oxidation to rifamycin S [4]. 
2. Materials and methods 
Rifamycin SV was obtained from Schwartz-Mann 
Inc. and ‘Spec-pure’ salts of the various metal ions 
from Johnson-Matthey Inc. 
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Spectra nd difference spectra were taken on a 
Cary 14 double beam spectrophotometer. Rate 
measurements were made using a Gilford Model 240 
spectrophotometer equipped in some cases with a 
Model 2445 Spectrospin accessory. The reaction rate 
was obtained either from the initial rate of the increase 
in absorbance at 536 nm or of the decrease in absor- 
bance at 444 mn. 
All other chemicals were A.R. grade reagents 
obtained from a reputable supply house. 
3. Results and discussion 
When the spectrum observed for a system con- 
taining 0.1 mM rifamycin SV t 0.1 mM MnC12 is 
compared using tandem cells with that of the 
individual components, a time-dependent appearance 
of a visible and ultraviolet difference spectrum is 
observed as illustrated in fig.1. The difference spectrum 
exhibits maxima t 266 nm, 320 nm, 358 mn and 
536 nm and minima at 236 nm, 296 mn, 345 mn and 
444 nm, while the final product of the reaction 
exhibits a spectrum with maxima t 3 13 nm and 
520 nm. Isosbestic points are observed at 249 nm, 
382 run and 494 mn (fig.1). Several lines of evidence 
indicate that these spectral changes induced by addi- 
tion of Mn2+ are due to oxidation of rifamycin SV to 
rifamycin S. First, the visible and ultraviolet spectrum 
of the product is identical to that previously reported 
for rifamycin S [4]. Second, analysis of the reaction 
mixture by paper chromatography during and after 
completion of the spectral change shows the 
progressive disappearance of the rifamycin SV spot 
and the appearance of a spot having an RF similar to 
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Fig.1. Difference spectrum generated by incubation of 
rifamycin SV with Mn? The incubation system contained, 
in 1.0 mi, 200 mM Na’ Hepes, pH 7.8, 0.1 mM rifamycin SV 
and 0.1 mM M&l,. The experiment was performed in tandem 
cells in which the compartments contained respectively 
buffer, buffer + rifamycm SV, buffer + M&l, and the 
complete system. The spectrum was scanned at 50 nm/min 
starting at 700 nm in a Cary 14 double beam recording 
spectrophotometer after initiation of the reaction by addition 
of MnCl,. The spectra shown were taken at O-9 min (A), 
12-21 min (B) and 40-49 min (C). In the latter case the 
reaction was complete and no further change in absorbance 
was detected on repeating the scan. A similar difference 
spectrum was generated if 100 mM MgCl, was used in place 
of MnCl, . 
that predicted for rifamycin S [5 ] . And three, gassing 
of the solutions with Na prevents the appearance of
the difference spectrum in a system containing Mn*’ 
whereas gassing with O2 somewhat accelerates this 
change suggesing that 02 may be required (table 1). 
Similar results are obtained using Mg*’ as the divalent 
cation (table 1). In order to achieve the effect of N2 
it is necessary to flush the solutions thoroughly with 
this gas before irritating the reaction. Both this 
observation and the finding that the reaction rate 
rapidly increases when the Na flow is discontinued 
in a stirred system suggest that the system has a high 
affkity for 02. 
The requirement for divalent metal ion in accelera- 
tion of the conversion of rifamycin SV to rifamycin S 
is indicated by the finding that chelating agents uch 
as EDTA and oxalate are effective inhibitors of this 
reaction when Mn*’ is the added metal ion. In contrast 
succinate which has a much lower affinity for Mn*’ 
has little effect (table 2). Similar esults were obtained 
when Mg” is added in place of Mn*‘. Examination of 
the specificity of the divalent metal ion effect shows 
that Mn*’ is by far the most effective of the species 
which catalyse the conversion. However, other metal 
ions, e.g., Co”, Ni*+, Cap and Mg** are effective 
although the concentrations required are generally 
greater, and/or the reaction rates lower, than those 
observed for Mnze (table 2). The observation of sig- 
Table 1 
Requirement for 0, in conversion of rifamycin SV to rifamycin S 
Additions Rate 
(A‘4 ,36 nm/minJ 
pH 8.5 Rifamycin SV (0.3 mMJ f 0, 0.0005 
+ MnSO, (1 mM) 0.083 
+ N, 0.00 
+ 0, 0.159 
pH 9.0 Rifamycin SV (0.3 mM) f 0, 0.0010 
+ MgSO, (9 mM) 0.0095 
+ N, 0.00 
+ 0, 0.014 
The assay system contained, in 3.0 ml, 100 mM Na+ Hepes at the pH indicated 
and the additions as described above. The solution in the cuvette was stirred in a 
_Gilford Model 240 spectrophotometer using a Model 2445 spectrostir accessory. 
0, or N, was introduced through a fine tube located in one comer of the 
cuvette and threaded through a channel in the lid to the cuvette chamber. 
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Table 2 
Requirement and specificity for divalent metal ions in conversion of rifamycin SV 
to rifamycin S 
Additions Rate 
(AA 536 nm/min) 
Rifamycin SV (0.5 mM) 
+ 8 mM EDTA, 10 mM oxalate or, 
10 mM succinate 
+ 2mMMnS0, 
+ 8 mMEDTA 
+ 10 mM succinate 
+ 2 mM Co(NO,), 
+ 2 mM_NiCl, 
0.0005 
0.0005 
0.850 
0.015 
0.620 
0.23 
0.06 
0.02 
0.99 
0.03 
0.71 
The assay system contained, in 3.0 ml, 100 mM Na’ Hepes, pH 8.2 (or pH 9.0 
where indicated) and the additions as indicated. Initial rates of increase in 
absorbance at 536 nm were measured in a stirred system as described for table 1. 
8 I- 
Fig.2. Effect of pH on the oxidation of rifamycin SV catalysed by Mn’: The incubation system contained, in 0.1 ml, 200 mM 
Na* Hepes of the appropriate pH, 2 mM M&l, and the concentrations of rifamycin SV as indicated. The reaction was initiated 
by addition of MnCl, and the initial rate obtained from the decrease in absorbance at 445 nm. In (A) the dependence of reci- 
procal initial rate (Expressed as l/A,4 .,rnm/min) on reciprocal rifamycin SV concentration is shown for a series of pH values as 
indicated, which were those observed for the complete assay medium. In (B) the apparent Vmax for the reaction is plotted as a 
function of pH. Curves similar in shape to that shown in (B) are generated when reaction is measured as a function of pH in the 
presence of Mg2+, Co’+ and Ni*+. The rates shown are corrected for the minimal change in absorbance observed in the absence of 
added metal ion. 
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nificant activation by MgF and Ca” is of considerable 
importance in regard to the role proposed for the 
metal ions in this reaction. 
When the initial rate of reaction is measured as a 
function of the concentration of rifamycin SV at a 
constant Mnp concentration, a hyperbolic relationship 
is observed indicating the formation of a rifamycin- 
Mn2’ complex (tig.2A). When such studies are con- 
ducted at a series of different pH values in the range 
pH 7-9, the ‘Km’ for rifamycin SV is found to vary 
little with H’ concentration over this range decreasing 
from a value of 1.8 mM, at pH 7.0, to 1.1 mM, at 
pH 9.2. Similar studies performed at a fixed pH (8.2) 
and a series of changing fixed concentrations of Mn2* 
in the range l-40 mM revealed that changes in metal 
ion concentration did not alter the nature of the 
dependence of initial rate on rifamycin SV concentra- 
tion and did not significantly alter the apparent Km 
for rifamycin SV. 
In contrast measurement of the initial rate of 
oxidation as a function of metal ion concentration 
at a fixed concentration of rifamycin approximating 
the Km reveals amore complex relationship if such 
studies are performed over a wide range of metal ion 
concentration. As shown in tig.3A the initial rate 
shows a clear biphasic dependence on the metal 
ion concentration for certain of the effective metal 
ions (Mn2’, Mg2’, Co2’, Ca2> although for Mg” and 
Cap the initial phase is much less marked than is the 
case for Mn2+ (fig3A). When Ni2* is the added metal 
ion the relationship approximates to a rectangular 
hyperbola over the range tested (l-1 00 mM) and no 
evidence was obtained for a further increase in rate 
at higher Ni” concentrations (fig.3B). It is notable 
that the maximal rate of oxidation obtained with 
Ni2’ is an order of magnitude lower than that 
observed for Mn2’ (fig.3) in accord with observations 
made at non-saturating metal ion concentrations 
(table 2). Thus the primary site responsible for cata- 
lysis of the oxidation of rifamycin SV may not be 
accessible to occupancy by Ni2’. 
The data presented permit several conclusions 
regarding catalysis of the oxidation of rifamycin SV 
to rifamycin S. This conversion can be effected by 
a wide range of oxidising agents including for example 
H202 and lead tetracetate, and also occurs when 
rifamycin SV is exposed in air over a long period [6]. 
It seems clear that such instability is attributable to 
metal ion catalysis of oxidation by O2 since in our 
hands olutions of rifamycin SV at pH 7 are stable 
if precautions are taken to exclude metal ions. Parti- 
cipation of the metal ion as electron carrier in the 
oxidation is excluded since Ca2* and Mg2’, which are 
effective catalysts at high concentration (table 2), 
cannot exist in more than one oxidation state. The 
marked increase in rate which is observed at alkaline 
pH for all effective metal ions suggest that a metal- 
hydroxide ion (M-OH) complex may be the active 
8 1 
Fig.3. Concentration dependence of the effect of M&l, (A) and NiCI, (B) on the oxidation of rifamycin SV. The incubation 
system contained, in 1.0 ml, 200 mM Na* Hepes, pH 8.0, 2 mM rifamycin SV and the concentration of metal ion as indicated. 
The reaction was initiated by addition of metal ran and the initial rate obtained from the increase in absorbance at 536 nm. 
Rates (v) are expressed as AA 116 nm/min.. 
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species. The initial EPR studies failed to detect forma- 
tion of a rifamycin SV-Mns’ complex having a dissocia- 
tion constant in the mM range, but a weaker inter- 
action could not have been detected and is in fact 
demonstrated by isolation of crystalline magnesium 
and calcium salts of rifamycin SV [4]. The salts form 
as a result of ionisation of the phenolic hydroxyl on 
the ring adjacent to the hydroquininoid system [6] 
which might be expected to labilise the hydroquinone 
system and hence promote its oxidation. Although 
ionisation of the phenolic hydroxyl might be expected 
to occur over the pH range xamined here, the failure 
to observe an effect of pH on the apparent ‘Km’ for 
rifamycin SV (fig.2) does not seem consistent with 
the involvement of this process in the rate-determining 
step of the oxidation. 
The initial studies were supported in part by 
USPHS grant No. GM 19402. 
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